GeneFinder™ COVID-19 Fast RealAmp Kit
GeneFinder™ COVID-19 Fast RealAmp Kit is designed for qualitative detection of SARS-CoV-2 RNA with real time reverse transcription PCR from Nasopharyn
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- T/T
- Production method
- ODM,OEM
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Medical Test Kit
OSANG HEALTHCARE CO., Ltd
South Korea
- Verified Certificate
-
16
| Product name | GeneFinder™ COVID-19 Fast RealAmp Kit | Certification | FDA , CE |
|---|---|---|---|
| Category | Medical Test Kit | Material | - |
| Keyword | pcr , covid-19 , ivdr | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | 5000 |
| Supply type | ODM,OEM | HS code | - |
Product Information
1. Principle
The testing principle of GeneFinder ™ COVID-19 Fast RealAmp Kit is One-Step Reverse Transcription Real-Time PCR with can be positively detected through reverse transcription and real-time polymerase chain reaction to confirm the presence of infected COVID-19 by amplifying the RdRp, E and N gene.
This product is an In vitro diagnostics (IVD) and is used by professionals in hospitals and laboratories.
2. Analytical Sensitivity : LOD
GeneFinder™ COVID-19 Fast RealAmp Kit was performed for analytical sensitivity with Target RNA.
As a result of experiments at various concentrations, the analytical sensitivity of the product was confirmed by RdRp gene; 5 copies/ul, E gene; 5 copies/ul, N gene; 2 copies /ul.
- Verified Certificate
-
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Express,Land Transportation,Negotiation Other,Ocean Shipping |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
OSANG HEALTHCARE CO., Ltd
-
16
- President
- SeunEuk Hong
- Address
- 132 Anyangcheondong-ro, Dongan-Gu, Dongan-gu, Anyang-si, Gyeonggi-do, Korea
- Product Category
- Medical Test Kit
- Year Established
- 1996
- No. of Total Employees
- 101-500
- Company introduction
-
OSANG Healthcare has been a leader in the Korean IVD (In-Vitro Diagnosis) industry since its founding in 1996, ever expanding a wide array of medical devices for biochemical, immunoassay, molecular diagnostics, and digital healthcare.
OSANG Healthcare Co., was the first South Korean SARS CoV 2 test kit producer to receive authorization from the U.S. Food & Drug Administration in April 2020.
The company has supplied countries all over the world and has already sold 760,000 tests to US customers, including the Federal Emergency Management Agency, Agency (FEMA). Giving the first priority to our customers and partners, we will further develop powerful synergies with other affiliates in the group.
- Main Markets
-
China
Germany
Greece
India
Indonesia
Iran
Italy
U.A.E.
U.S.A
Viet Nam
Yemen
- Factory Information
-
Osang Healthcare
- Main Product
- Attached File
